A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
Clinical trial NCT00067730 · COMPLETED
Trial details
- NCT number
- NCT00067730
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.